Company: MVIS
Filing Date: 2025-02-03
Form Type: 424B5
Source: 0001493152-25-004622
Chunk: 6

Company: MICROVISION, INC.
Filing Date: 2025-02-03
Form: 424B5
Chunk 6
---
, under our 2022 Incentive Plan, as amended, or the Incentive Plan;                          |
| ● | 12,023,477                                                                                                                    
 shares of our common stock underlying unvested and/or deferred stock awards;                                                  |
| ● | 2,184,223                                                                                                                     
 shares of our common stock reserved for issuance pursuant to the Incentive Plan; and                                          |
| ● | 5,750,225                                                                                                                     
 shares of our common stock issuable upon exercise                                                                             
 of the warrants to be offered in this offering.                                                                               |

The number of shares outstanding shown above does not reflect any issuances of shares following September 30, 2024, including shares of our common stock issuable to High Trail Special Situations LLC upon exercise of that certain senior secured convertible note in the aggregate principal amount of $45,000,000 sold by us pursuant to the Securities Purchase Agreement dated October 14, 2024, in a private placement that we consummated on October 23, 2024.

| S-3 |

<div align='center'>RISK FACTORS</div>

An investment in our securities involves a high degree of risk. You should carefully consider all of the information in this prospectus supplement and the accompanying prospectus, including the risks and uncertainties described below, and all other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus, before you decide whether to purchase our securities. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. If any of these risks were to occur, our business, financial condition or results of operations would likely suffer. In that event, the trading price of our common stock could decline and you could lose all or part of your investment.

Risks Related to Our Common Stock, Warrants and this Offering

We have broad discretion in the use of the net proceeds from this offering and may not use them effectively.

Our management will have broad discretion in the application of the net proceeds from this offering and could spend the proceeds in ways that do not necessarily improve our results of operations or enhance the value of our common stock. Our failure to apply these funds effectively could have a material adverse effect on our business, financial condition, operating results and cash flow, and could cause the price of our common stock to decline.

If you purchase the common stock sold in this offering, you will experience immediate and substantial dil